Login Open an Account

Nippon India Pharma Fund - Growth Plan - Growth Option

Equity Create Wealth

Sectoral Fund - Pharma & Health Care

Category Rank

Rating

The fund has a very high portfolio turnover which implies high churn and does not let the power of compounding set in
It holds a large number of poor quality high risk stocks

Fund

Fund sahi hai

Time to Invest

NAV

Rs.506.584 (20/06/2025)

	L 52Wk H
442.69		530.57

Asset Allocation for Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Growth Plan - Growth Option

58.43 % of total assets

Sun Pharmaceutical Industries Limited(12.57%)

Divi's Laboratories Limited(9.49%)

Lupin Limited(5.82%)

Cipla Limited(5.62%)

Dr. Reddy's Laboratories Limited(5.49%)

Apollo Hospitals Enterprise Limited(5.35%)

MedPlus Health Services Limited(4.20%)

GlaxoSmithKline Pharmaceuticals Limited(3.73%)

Vijaya Diagnostic Centre Limited(3.24%)

Narayana Hrudayalaya Limited(2.94%)

Detailed Portfolio of Nippon India Pharma Fund - Growth Plan - Growth Option

                    Portfolio Date -31 May 2025 

                    Equity Holdings -36 

                    Other Holdings -3 

Equity Holdings
Debt Holdings
Other Holdings

Holdings	% Weight	Value	Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited	12.57%	1049.565 Cr
Divi's Laboratories Limited	9.49%	792.652 Cr
Lupin Limited	5.82%	486.291 Cr
Cipla Limited	5.62%	469.024 Cr
Dr. Reddy's Laboratories Limited	5.49%	458.211 Cr
Apollo Hospitals Enterprise Limited	5.35%	446.403 Cr
MedPlus Health Services Limited	4.20%	350.540 Cr
GlaxoSmithKline Pharmaceuticals Limited	3.73%	311.299 Cr
Vijaya Diagnostic Centre Limited	3.24%	270.783 Cr
Narayana Hrudayalaya Limited	2.94%	245.357 Cr
Gland Pharma Limited	2.91%	242.953 Cr
Ajanta Pharma Limited	2.88%	240.867 Cr
Abbott India Limited	2.87%	239.611 Cr
Dr. Lal Path Labs Limited	2.37%	197.601 Cr
Aurobindo Pharma Limited	2.34%	195.428 Cr
Mankind Pharma Limited	2.24%	186.927 Cr
Zydus Lifesciences Limited	2.23%	186.059 Cr
Thyrocare Technologies Limited	2.22%	185.272 Cr
Pfizer Limited	2.14%	178.643 Cr
JB Chemicals & Pharmaceuticals Limited	2.01%	167.571 Cr
Alkem Laboratories Limited	1.98%	165.027 Cr
Sanofi India Limited	1.71%	142.596 Cr
Sai Life Sciences Limited	1.40%	116.962 Cr
Sanofi Consumer Healthcare India Limited	1.35%	112.568 Cr
IPCA Laboratories Limited	1.34%	111.906 Cr
Suraksha Diagnostic Limited	1.22%	101.776 Cr
Torrent Pharmaceuticals Limited	1.15%	96.309 Cr
Fortis Healthcare Limited	0.93%	77.968 Cr
Biocon Limited	0.92%	76.716 Cr
Syngene International Limited	0.87%	72.724 Cr
Emcure Pharmaceuticals Limited	0.75%	62.542 Cr
AstraZeneca Pharma India Limited	0.61%	51.083 Cr
Akums Drugs and Pharmaceuticals Limited	0.57%	47.639 Cr
Indoco Remedies Limited	0.55%	45.998 Cr
Orchid Pharma Limited	0.37%	30.980 Cr
Concord Biotech Limited	0.23%	19.537 Cr

Holdings	% Weight	Value	Sahi Hai/Nahi

Holdings	% Weight	Value	Sahi Hai/Nahi
Triparty Repo	1.52%	127.296 Cr	-
Cash Margin - CCIL	0.00%	0.062 Cr	-
Net Current Assets	-0.10%	-8.580 Cr	-

Insight on the composition of the Nippon India Pharma Fund - Growth Plan - Growth Option

Related Funds

Nippon india
Pharma fund
- idcw...

The scheme is a dividend payout scheme which is usually not recommended since investor miss out on the compounded returns of reinvestment or growth schemes.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Icici prudential
Pharma healthcare
And diagnostics...

The overall quality of stocks in the fund portfolio is poor.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Sbi healthcare
Opportunities fund
Regular idcw...

The overall quality of stocks in the fund portfolio is poor.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Dsp healthcare
Fund -
Regular -...

The overall quality of stocks in the fund portfolio is poor.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Mirae asset
Healthcare fund
- regular...

It holds a large number of poor quality high risk stocks
The scheme is a dividend payout scheme which is usually not recommended since investor miss out on the compounded returns of reinvestment or growth schemes.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Hdfc pharma
And healthcare
Fund regular...

It has a relatively higher expense ratio
The scheme is a dividend payout scheme which is usually not recommended since investor miss out on the compounded returns of reinvestment or growth schemes.

Since this is a low rated equity scheme, RANK MF research recommends that Investors should look for alternative better Equity schemes

Pharma & Health Care Companies

Invest Now

Top Ranked Funds

Parag parikh
Elss tax
Saver fund...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
The relatively volatility and risk of the fund is lower than other funds in the category
The fund does not hold too many high risk stocks which results in relatively higher strength of the fund

Fund sahi hai

ELSS - Equity Linked Savings Scheme

Save Tax and Create Wealth

Invest Now

Tata bse
Quality index
Fund regular...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
The fund does not hold too many high risk stocks which results in relatively higher strength of the fund

Fund sahi hai

Index Funds - Other

Get Index returns at low cost

Invest Now

Franklin india
Bluechip fund
- growth...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
The relatively volatility and risk of the fund is lower than other funds in the category

Fund sahi hai

Large Companies

Invest Now

Dsp nifty
Private bank
Index fund...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
The fund does not hold too many high risk stocks which results in relatively higher strength of the fund

Fund sahi hai

Index Funds - Other

Get Index returns at low cost

Invest Now

Kotak nifty
Top 10
Equal weight...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
It has the one of the lowest expense ratio’s in the category
The fund does not hold too many high risk stocks which results in relatively higher strength of the fund

Fund sahi hai

Index Funds - Other

Get Index returns at low cost

Invest Now

Hdfc nifty
50 index
Fund -...

It holds a relatively good and strong portfolio of stocks
It’s ability to generate return by taking relatively lower risk is much better than other funds in the category
It has the one of the lowest expense ratio’s in the category

Fund sahi hai

Index Funds of Nifty - Top 50 Indian Companies

Get Index returns at low cost

Invest Now

Top s

Nippon india
Gold savings
Fund -...

The fund has relatively the lowest expense ratio than most funds in the category
The fund is optimally managed

Fund sahi hai

Invest Now

Nippon india
Equity savings
Fund--growth ...

It's ability to generate return by taking relatively lower risk is much better than other funds in the category

Fund sahi hai

Mix of Stocks, Fixed Income and Other instruments

Generate Income and create wealth

Invest Now

Nippon india
Retirement fund-income
Generation scheme-growth...

The fund expense ratio is lower than most of funds in the category

Fund sahi hai

Large, Medium and Small Companies

Invest Now

Nippon india
Nivesh lakshya
Fund -...

The fund has outstanding portfolio and very low credit default risk
The fund has low sensitivity to interest rate fluctuations as compared to others funds in the category

Fund sahi hai

Long Term Debt assets

Generate Interest income and beat FD returns

Invest Now

Nippon india
Corporate bond
Fund -...

The fund has strong portfolio and relatively low credit default risk
The fund has above average yield(expected return) as compared to other funds in the category
The fund has lower interest rate risk as compared to others funds in the category

Fund sahi hai

Fixed Income Instruments

Generate Interest income and beat FD returns

Invest Now

Nippon india
Short term
Fund-growth plan...

The fund has above average yield(expected return) as compared to other funds in the category
The fund has lower interest rate risk as compared to others funds in the category

Fund sahi hai

Short Term Debt assets

Generate Interest income and beat FD returns

Invest Now